Pruritus News and Research

RSS
Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Zyclara 3.75% more effective than cryotherapy alone in treatment of Actinic Keratoses: Study

Zyclara 3.75% more effective than cryotherapy alone in treatment of Actinic Keratoses: Study

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Talecris Biotherapeutics announces 2010 eALTA award recipients

Talecris Biotherapeutics announces 2010 eALTA award recipients

FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence

FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Incyte Corporation enters SPA agreement with FDA for INCB18424 inhibitor

Incyte Corporation enters SPA agreement with FDA for INCB18424 inhibitor

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

USPTO awards Medicis new patent for SOLODYN Extended Release Tablets

USPTO awards Medicis new patent for SOLODYN Extended Release Tablets

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

FDA approves LUMIGAN eye drops for intraocular pressure reduction in open-angle glaucoma patients

FDA approves LUMIGAN eye drops for intraocular pressure reduction in open-angle glaucoma patients

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

FDA approves additional strengths of SOLODYN for inflammatory lesions treatment

FDA approves additional strengths of SOLODYN for inflammatory lesions treatment

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Vertex reports results from Phase 3 ILLUMINATE study of telaprevir-based therapy for hepatitis C

Endo to acquire Penwest for $5.00 per share

Endo to acquire Penwest for $5.00 per share

FDA accepts Salix's XIFAXAN550 sNDA for Priority Review

FDA accepts Salix's XIFAXAN550 sNDA for Priority Review